SCHEMBL20195353

SCHEMBL20195353

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cc(-c5ccc(-c6ccccn6)cc5)cc(-c5ccc(-c6ccccn6)cc5)c4)c4ccccc34)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPK1 P28482 2/20 0.48
RAB9A P51151 6/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HPGD P15428 4/20 0.47
LMNA P02545 4/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.47
TP53 P04637 3/20 0.47
PKM P14618 2/20 0.47
KLF5 Q13887 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
DHODH Q02127 1/20 0.45
METAP1 P53582 2/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
NPC1 O15118 4/20 0.42
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21098948 0.96 TSHR (0.46) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL21099059 0.92 SMN1; SMN2 (0.46) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL17829422 0.91 KDM4E (0.52) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL21099056 0.90 KDM4E (0.46) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL21098923 0.89 HSD17B10 (0.42) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL17829306 0.88 KDM4E (0.50) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL9958139 0.88 ALDH1A1 (0.47) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL18334141 0.88 KDM4E (0.46) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL16407280 0.87 HSD17B10 (0.40) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2
SCHEMBL17598615 0.87 KDM4E (0.50) TSHRHSD17B10MAPK1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323006-B2 Heterocyclic compound and organic light emitting element using same LG CHEM, LTD. (KR) 2019-06-18 US disclosed
EP-3327008-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG Chem, Ltd. (KR) 2018-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10323006-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, NR2E3 TSHR 3517/4885HSD17B10 2186/4885MAPK1 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.